Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the successful European human implantation of its new interbody spacer. The nanOss Cervical cage is machined from robust nanocrystalline hydroxyapatite (HA) and is designed for use in the cervical spine for the treatment of cervical disc disease. The surgeries were performed at hospitals in the United Kingdom and are the first expansion of Pioneer’s Biologics products into Europe.
Regarding Pioneer’s latest product introduction Mr. Shane Ray, General Manager – Biologics for Pioneer stated, “We are very pleased to expand our interbody product offerings into Europe with nanOss Cervical and to utilize the alliance with our sales, technical, and support team in Europe. This novel product is the first of its kind composed of hydroxyapatite to provide strength as a cervical spacer. We look forward to expanded sales of nanOss Cervical throughout key markets within and outside Europe.”
For more information regarding Pioneer’s Biologics product offerings, including nanOss Cervical, please visit thePioneer Surgical website.
About Pioneer Surgical Technology, Inc.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer’s focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopedic, Spine, and Biologics divisions produce state-of-the-art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products, visithttp://www.pioneersurgical.com.